BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 28651919)

  • 21. Echocardiographic pulmonary hypertension probability is associated with clinical outcomes after transcatheter aortic valve implantation.
    Nijenhuis VJ; Huitema MP; Vorselaars VM; Swaans MJ; de Kroon T; van der Heyden JA; Rensing BJ; Heijmen R; Ten Berg JM; Post MC
    Int J Cardiol; 2016 Dec; 225():218-225. PubMed ID: 27732925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome prediction following transcatheter aortic valve implantation: Multiple risk scores comparison.
    Zbroński K; Huczek Z; Puchta D; Paczwa K; Kochman J; Wilimski R; Scisło P; Rymuza B; Filipiak KJ; Opolski G
    Cardiol J; 2016; 23(2):169-77. PubMed ID: 26711463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of long-term survival following transcatheter aortic valve implantation from a single high-volume center.
    Escárcega RO; Lipinski MJ; Baker NC; Magalhaes MA; Minha S; Torguson R; Chen F; Ben-Dor I; Satler LF; Pichard AD; Corso P; Waksman R
    Am J Cardiol; 2015 Jul; 116(2):256-63. PubMed ID: 25978977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of Patients at Estimated Low, Intermediate, and High Risk Undergoing Transcatheter Aortic Valve Implantation for Aortic Stenosis.
    Barbash IM; Finkelstein A; Barsheshet A; Segev A; Steinvil A; Assali A; Ben Gal Y; Vaknin Assa H; Fefer P; Sagie A; Guetta V; Kornowski R
    Am J Cardiol; 2015 Dec; 116(12):1916-22. PubMed ID: 26602076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of liver dysfunction assessed by MELD-XI scoring system in patients undergoing transcatheter aortic valve implantation.
    Arai T; Yashima F; Yanagisawa R; Tanaka M; Shimizu H; Fukuda K; Watanabe Y; Naganuma T; Araki M; Tada N; Yamanaka F; Shirai S; Yamamoto M; Hayashida K;
    Int J Cardiol; 2017 Feb; 228():648-653. PubMed ID: 27883976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preprocedural but not periprocedural high-sensitive Troponin T levels predict outcome in patients undergoing transcatheter aortic valve implantation.
    Köhler WM; Freitag-Wolf S; Lambers M; Lutz M; Niemann PM; Petzina R; Lutter G; Bramlage P; Frey N; Frank D
    Cardiovasc Ther; 2016 Dec; 34(6):385-396. PubMed ID: 27380819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients With Chronic Kidney Disease Stages 3b to 5.
    D'Errigo P; Moretti C; D'Ascenzo F; Rosato S; Biancari F; Barbanti M; Santini F; Ranucci M; Miceli A; Tamburino C; Onorati F; Santoro G; Grossi C; Fusco D; Seccareccia F;
    Ann Thorac Surg; 2016 Aug; 102(2):540-7. PubMed ID: 27130249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve Replacement: Results From the Italian OBSERVANT Study.
    Tamburino C; Barbanti M; D'Errigo P; Ranucci M; Onorati F; Covello RD; Santini F; Rosato S; Santoro G; Fusco D; Grossi C; Seccareccia F;
    J Am Coll Cardiol; 2015 Aug; 66(7):804-812. PubMed ID: 26271063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends over the past 4 years in population characteristics, 30-day outcomes and 1-year survival in patients treated with transcatheter aortic valve implantation.
    Avinée G; Durand E; Elhatimi S; Bauer F; Glinel B; Dacher JN; Cellier G; Viart G; Tron C; Godin M; Litzler PY; Cribier A; Eltchaninoff H
    Arch Cardiovasc Dis; 2016; 109(8-9):457-64. PubMed ID: 27342810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Serum C-Reactive Protein Level on Admission to Predict Mortality After Transcatheter Aortic Valve Implantation.
    Hioki H; Watanabe Y; Kozuma K; Yamamoto M; Naganuma T; Araki M; Tada N; Shirai S; Yamanaka F; Higashimori A; Mizutani K; Tabata M; Takagi K; Ueno H; Hayashida K;
    Am J Cardiol; 2018 Jul; 122(2):294-301. PubMed ID: 29735216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement in Risk Stratification in Transcatheter Aortic Valve Implantation Using a Combination of the Tumor Marker CA125 and the Logistic EuroSCORE.
    Husser O; Núñez J; Burgdorf C; Holzamer A; Templin C; Kessler T; Bodi V; Sanchis J; Pellegrini C; Luchner A; Maier LS; Schmid C; Lüscher TF; Schunkert H; Kastrati A; Hilker M; Hengstenberg C
    Rev Esp Cardiol (Engl Ed); 2017 Mar; 70(3):186-193. PubMed ID: 27623490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of kidney function on mortality after transcatheter valve implantation in patients with severe aortic valvular stenosis.
    Voigtländer L; Schewel J; Martin J; Schewel D; Frerker C; Wohlmuth P; Thielsen T; Kuck KH; Schäfer U
    Int J Cardiol; 2015 Jan; 178():275-81. PubMed ID: 25464269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation.
    Elhmidi Y; Bleiziffer S; Piazza N; Ruge H; Krane M; Deutsch MA; Hettich I; Voss B; Mazzitelli D; Lange R
    J Invasive Cardiol; 2013 Jan; 25(1):38-44. PubMed ID: 23293174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of the "TAVI2-SCORe" versus surgical risk scores for prediction of one year mortality in 511 patients who underwent transcatheter aortic valve implantation.
    Debonnaire P; Fusini L; Wolterbeek R; Kamperidis V; van Rosendael P; van der Kley F; Katsanos S; Joyce E; Tamborini G; Muratori M; Gripari P; Bax JJ; Marsan NA; Pepi M; Delgado V
    Am J Cardiol; 2015 Jan; 115(2):234-42. PubMed ID: 25432413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter aortic valve implantation in patients with LV dysfunction: impact on mortality and predictors of LV function recovery.
    Elhmidi Y; Bleiziffer S; Deutsch MA; Krane M; Mazzitelli D; Lange R; Piazza N
    J Invasive Cardiol; 2014 Mar; 26(3):132-8. PubMed ID: 24610508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of chronic kidney disease after transcatheter aortic valve implantation.
    Yamamoto M; Hayashida K; Mouillet G; Hovasse T; Chevalier B; Oguri A; Watanabe Y; Dubois-Randé JL; Morice MC; Lefèvre T; Teiger E
    J Am Coll Cardiol; 2013 Sep; 62(10):869-77. PubMed ID: 23707321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of body mass index in transcatheter aortic valve implantation: A "J"-shaped curve.
    González-Ferreiro R; Muñoz-García AJ; López-Otero D; Avanzas P; Pascual I; Alonso-Briales JH; Trillo-Nouche R; Pun F; Jiménez-Navarro MF; Hernández-García JM; Morís C; González Juanatey JR
    Int J Cardiol; 2017 Apr; 232():342-347. PubMed ID: 28089155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
    López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
    Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nutritional risk index predicts survival in patients undergoing transcatheter aortic valve replacement.
    González Ferreiro R; Muñoz-García AJ; López Otero D; Avanzas P; Pascual I; Alonso-Briales JH; González-Juanatey JR; Pun F; Jiménez-Navarro MF; Hernández-García JM; Morís C; Trillo Nouche R
    Int J Cardiol; 2019 Feb; 276():66-71. PubMed ID: 30473334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of coronary artery disease in patients undergoing transfemoral transcatheter aortic valve implantation.
    Shamekhi J; Stundl A; Weber M; Mellert F; Welz A; Grube E; Nickenig G; Werner N; Sinning JM
    Int J Cardiol; 2017 Oct; 245():215-221. PubMed ID: 28789844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.